Macleods Pharmaceuticals recalls

Macleods Pharmaceuticals has 3 recalls on record with the FDA and USDA, the earliest in 2024 and the latest reported on 16 Jul 2025. 3 are still ongoing. The most frequent reason is packaging defects.

Total recalls3since 2024

Last 12 months0reported

Class I00% of total

Ongoing3latest 16 Jul 2025

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 1 0Jan '25 0 0 0Apr 0 1 1Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 1 33%Class III 2 67%

Why macleods pharmaceuticals is recalled

Product types

Thyroid Medication133%

Brands

By year

2025267%
2024133%

Ongoing macleods pharmaceuticals recalls

3 active

Reported	Class	Recall	Company	Reason	Where
16 Jul 2025Drug	CLASS III	Famciclovir Tablets, USP 500 mg recalled by Macleods PharmaceuticalsFamciclovir	Macleods Pharmaceuticals	Packaging Defects	Nationwide
18 Jun 2025Drug	CLASS III	Levothyroxine Sodium Tablets, USP 112 mcg 112mg) recalledLevothyroxine Sodium	Macleods Pharmaceuticals	Other	Nationwide
25 Dec 2024Drug	CLASS II	Olanzapine Tablets, USP 5 mg recalled by Macleods PharmaceuticalsOlanzapine	Macleods Pharmaceuticals	Potency & Assay	Nationwide

All macleods pharmaceuticals recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
16 Jul 2025Drug	CLASS III	Famciclovir Tablets, USP 500 mg recalled by Macleods PharmaceuticalsFamciclovir	Macleods Pharmaceuticals	Packaging Defects	Nationwide
18 Jun 2025Drug	CLASS III	Levothyroxine Sodium Tablets, USP 112 mcg 112mg) recalledLevothyroxine Sodium	Macleods Pharmaceuticals	Other	Nationwide
25 Dec 2024Drug	CLASS II	Olanzapine Tablets, USP 5 mg recalled by Macleods PharmaceuticalsOlanzapine	Macleods Pharmaceuticals	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.